Eastwood Bio-Medical Canada Inc (EBM) — Cash Flow Reinvestment Rate
Eastwood Bio-Medical Canada Inc (EBM) has a Cash Flow Reinvestment Rate of 0.00x as of April 2025, reinvesting CA$0.00 (capex CA$0.00 ) from operating cash flow of CA$12.93K. Explore Eastwood Bio-Medical Canada Inc (EBM) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eastwood Bio-Medical Canada Inc Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Eastwood Bio-Medical Canada Inc across 2 annual periods. Also explore EBM asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Eastwood Bio-Medical Canada Inc (2014–2025)
Year-by-year capital reinvestment analysis for Eastwood Bio-Medical Canada Inc. For live market cap and broader valuation context, see EBM market cap.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | CA$0.00 | CA$19.30K | CA$0.00 | ▼ -100.0% |
| 2014 | 0.35x | CA$550.00K | CA$1.58 Million | CA$0.00 | — |